Fingolimod is an immunomodulating drug. It is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis
Patnaik stressed early diagnosis, rapid treatment, and aggressive surveillance as the backbone of elimination efforts
Health Ministry reviews progress, highlights targeted interventions in high-burden states, and calls for stronger surveillance and stigma reduction to achieve a leprosy-free India
The regulatory decision follows promising results from RIVER-81
Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings
The Prayagraj lab is designed to handle both routine and specialised testing
The launch comes against the backdrop of a significant public health burden
The company will present 21 oral and poster presentations spanning investigational and approved therapies
The campaign places renewed focus on a disease that remains incurable despite major scientific advances
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Subscribe To Our Newsletter & Stay Updated
